These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 16417029)

  • 1. Preoperative low molecular weight heparin as venous thromboembolism prophylaxis in patients at risk for prosthetic infection after knee arthroplasty.
    Asensio A; Ramos A; Múñez E; Vilanova JL; Torrijos P; García FJ
    Infect Control Hosp Epidemiol; 2005 Dec; 26(12):903-9. PubMed ID: 16417029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Timing of DVT prophylaxis and risk of postoperative knee prosthesis infection.
    Asensio A; Antolín FJ; Sanchez-García JM; Hidalgo O; Hernández-Navarrete MJ; Bishopberger C; Miguel LG; Gay-Pobes A; Cabrera-Quintero A; Asensio P; Sanz-Sebastián C; Gonzalez-Torga A; Ortiz-Espada A; Pérez-Serrano L; Ramos A
    Orthopedics; 2010 Nov; 33(11):800. PubMed ID: 21053884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wound complications following rivaroxaban administration: a multicenter comparison with low-molecular-weight heparins for thromboprophylaxis in lower limb arthroplasty.
    Jameson SS; Rymaszewska M; Hui AC; James P; Serrano-Pedraza I; Muller SD
    J Bone Joint Surg Am; 2012 Sep; 94(17):1554-8. PubMed ID: 22832942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extended-duration low-molecular-weight heparin prophylaxis following total joint arthroplasty.
    Whang PG; Lieberman JR
    Am J Orthop (Belle Mead NJ); 2002 Sep; 31(9 Suppl):31-6. PubMed ID: 12349893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of major venous thromboembolism following total hip or knee replacement: a randomized comparison of low-molecular-weight heparin with unfractionated heparin (ECHOS Trial).
    Haas S; Breyer HG; Bacher HP; Fareed J; Misselwitz F; Victor N; Weber J;
    Int Angiol; 2006 Dec; 25(4):335-42. PubMed ID: 17164738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty.
    Patel VP; Walsh M; Sehgal B; Preston C; DeWal H; Di Cesare PE
    J Bone Joint Surg Am; 2007 Jan; 89(1):33-8. PubMed ID: 17200307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of thromboprophylaxis with low-molecular-weight heparin or rivaroxaban in hip and knee replacement surgery: findings from the ORTHO-TEP registry.
    Beyer-Westendorf J; Lützner J; Donath L; Tittl L; Knoth H; Radke OC; Kuhlisch E; Stange T; Hartmann A; Günther KP; Weiss N; Werth S
    Thromb Haemost; 2013 Jan; 109(1):154-63. PubMed ID: 23197272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DVT prophylaxis after TKA: routine anticoagulation vs risk screening approach - a randomized study.
    Kulshrestha V; Kumar S
    J Arthroplasty; 2013 Dec; 28(10):1868-73. PubMed ID: 23796558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prophylaxis for deep vein thrombosis with low molecular weight heparin following hip and knee surgery].
    Li XL; Lu WJ; Yu NS
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2001 Jan; 15(1):39-41. PubMed ID: 12563929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dental procedures as risk factors for prosthetic hip or knee infection: a hospital-based prospective case-control study.
    Berbari EF; Osmon DR; Carr A; Hanssen AD; Baddour LM; Greene D; Kupp LI; Baughan LW; Harmsen WS; Mandrekar JN; Therneau TM; Steckelberg JM; Virk A; Wilson WR
    Clin Infect Dis; 2010 Jan; 50(1):8-16. PubMed ID: 19951109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying orthopedic patients at high risk for venous thromboembolism despite thromboprophylaxis.
    Schiff RL; Kahn SR; Shrier I; Strulovitch C; Hammouda W; Cohen E; Zukor D
    Chest; 2005 Nov; 128(5):3364-71. PubMed ID: 16304285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A combination of arteriovenous impulse system and low-molecular-weight heparins calcium for prophylaxis of deep venous thrombosis following total knee arthroplasty].
    Cao J; Wang J; Zhang H; Wang L
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2010 May; 24(5):538-40. PubMed ID: 20540254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for prosthetic hip and knee infections according to arthroplasty site.
    Peel TN; Dowsey MM; Daffy JR; Stanley PA; Choong PF; Buising KL
    J Hosp Infect; 2011 Oct; 79(2):129-33. PubMed ID: 21821313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcutaneous low-molecular-weight heparin vs warfarin for prophylaxis of deep vein thrombosis after hip or knee implantation. An economic perspective.
    Hull RD; Raskob GE; Pineo GF; Feldstein W; Rosenbloom D; Gafni A; Green D; Feinglass J; Trowbridge AA; Elliott CG
    Arch Intern Med; 1997 Feb; 157(3):298-303. PubMed ID: 9040296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thromboprophylaxis, bleeding and post-operative prosthetic joint infection in total hip and knee arthroplasty: a comprehensive literature review.
    Kwong LM; Kistler KD; Mills R; Wildgoose P; Klaskala W
    Expert Opin Pharmacother; 2012 Feb; 13(3):333-44. PubMed ID: 22220855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rationale for low-molecular-weight heparin prophylaxis after total knee arthroplasty.
    Colwell CW; Hardwick ME
    Clin Orthop Relat Res; 2006 Nov; 452():181-5. PubMed ID: 17016231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanical and suboptimal pharmacologic prophylaxis and delayed mobilization but not morbid obesity are associated with venous thromboembolism after total knee arthroplasty: a case-control study.
    Sadeghi B; Romano PS; Maynard G; Strater AL; Hensley L; Cerese J; White RH
    J Hosp Med; 2012; 7(9):665-71. PubMed ID: 23042665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolism.
    Creekmore FM; Oderda GM; Pendleton RC; Brixner DI
    Pharmacotherapy; 2006 Oct; 26(10):1438-45. PubMed ID: 16999654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dabigatran: new drug. Continue to use heparin, a better-known option.
    Prescrire Int; 2009 Jun; 18(101):97-9. PubMed ID: 19637411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.